InvestorsHub Logo

jammy32

06/06/23 11:57 AM

#380759 RE: The ELTP King #380757

And somehow they will still lose. Just so sad

JamesF1

06/06/23 12:15 PM

#380760 RE: The ELTP King #380757

For Isradipine the competition is Teva. It is a niche product with low demand, but with a decent profit margin. It is probably not much of a priority for Teva. For a little company like Elite, it definitely helps.

NASDAQ2020

06/06/23 12:18 PM

#380761 RE: The ELTP King #380757

They sold it all , in shortage
Bullish
Bullish